ACADIA Pharmaceuticals Financial Statements
ACADIA Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
ACADIA Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 7.6 | 8.1 | 11.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (62.7) | (49.0) | (35.8) |
| Total Net Income ($ mil.) | (56.4) | (45.0) | (34.1) |
| Diluted EPS (Net Income) | (1.60) | (1.61) | (1.55) |
ACADIA Pharmaceuticals Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.2 | 0.8 | 1.6 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (19.0) | (17.6) | (18.7) |
| Total Net Income ($ mil.) | (18.3) | (16.4) | (17.0) |
| Diluted EPS (Net Income) | (0.50) | (0.44) | (0.46) |
ACADIA Pharmaceuticals Stock Quote & Chart
09/05/08 15:00:08 EST •
NASDAQ •
2.82
•
 +0.4200
•
+17.5000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
ACADIA Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 25.28 | 3.75 | 1.56 |
| Price/Earnings Ratio | -- | 16.34 | 15.82 |
| Price/Book Ratio | 1.41 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | -- | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed ACADIA Pharmaceuticals Financial Ratios
ACADIA Pharmaceuticals Competitive Intelligence
| AstraZeneca | Eli Lilly | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | -- | 18,633.5 | 48,418.0 |
| Employees | -- | 40,600 | 86,600 |
| Market Cap ($ mil.) | -- | 54,960.2 | 133,815.6 |
Competitive Landscape
